Pharmacokinetics and dynamics Flashcards

1
Q

Michaelis-Menten Kinetics

A

Velocity on Y-axis, [S] on X-axis

Km, Vmax are found on this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Km

A

inversely related to the affinity of the enzyme for the substrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Vmax

A

directly proportional to the enzyme concentration

half of Vmax is how you find Km on the X-axis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lineweaver-Burk Plot

A

Plotted line crossed the Y-axis
1/V on Y axis; 1/[S] on X-axis
1/(Vmax) is when plotted line touches Y-axis
1/-Km on X-axis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharmacokinetics

A

The effects of the body on the drug

Absorption, Distribution, Metabolism, Excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharmacodynamics

A

The effects of the drug on the body

includes concepts of receptor binding, drug efficacy, drug potency and toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bioavailability (F)

A

Fraction of administered drug that reaches systemic circulation unchanged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bioavailability for IV dose

A

F = 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Volume of Distribution (Vd)

A

(amt drug in body)/([plasma drug])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Vd for large/charged molecules; plasma protein bound

A

Low Vd, in blood compartment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Vd for small hydrophilic molecules

A

Medium Vd, in ECF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vd for small lipophilic molecules, esp if bound to tissue protein

A

High Vd, in all tissues including fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Half lives to reach steady state

A

need 4-5 t1/2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Eqtn for T1/2

A

(0.639*Vd)/(CL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clearance

A

CL = (rate of elimination of drug)/([plasma drug])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Zero Order Elimination

A

Plasma concentratino decreases linearly with time
Constant amount of drug eliminated per unit time
Phenytoin, Ethanol, Aspirin

17
Q

First Order Elimination

A

Rate of elimination is directly proportional to drug concentration

18
Q

Weak Acid Drugs

A

Phenobarbital, Methotrexate, Aspirin

Trap in basic environments so tx overdose with bicarbonate

19
Q

Weak Base Drugs

A

Amphetamines

Trap in acidic environments so tx overdose with ammonium chloride

20
Q

Phase I drug metabolism

A

Reduction, Oxidation, Hydrolysis with cyto P450

Geriatrics lose phase I first

21
Q

Phase II drug metabolism

A

Conjugation (Glucuronidation, Acetylation, Sulfation)

yields very polar, inactive metabolites

22
Q

Slow acetylators

A

Great S/E from drugs because decreased rate of metabolism

23
Q

Efficacy

A

Maximal Effect a drug can produce

24
Q

Partial Agonists

A

less efficacy than full agonists

25
Q

Potency

A

Amount of drug needed for a given effect

26
Q

Competitive Antagonist

A

shifts curve to right (decreases potency), no change in efficacy. Can be overcome by increase conc of agonist

27
Q

Noncompetitive Antagonist

A

Shifts curve down to decrease efficacy.

Cannot be overcome with increase agonist substrate

28
Q

Irreversible competitive antagonist

A

Shifts curve down to decrease efficacy.

Cannot be overcome with increase agonist substrate

29
Q

Partial Agonist

A

Acts on same site as full agonist but with lower efficacy. Potency is variable.

30
Q

Therapeutic Index

A

Measurement of Drug Safety

between ED50 and TD50 on graph or = TD50/ED50

31
Q

High Therapeutic Index

A

safer drug

32
Q

Low therapeutic Index

A

more dangerous drug

33
Q

LD50

A

median lethal dose

34
Q

TD50

A

median toxic dose

35
Q

Therapeutic Window

A

measure of clinical drug effectiveness

36
Q

ED

A

effective dose